Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7737288 | Non-steroidal androgen receptor modulators, preparation process, pharmaceutical composition and use thereof Non-steroidal androgen receptor modulating compounds of the general formula (I), their pharmaceutically acceptable salts, preparation process and pharmaceutically compositions containing the said compounds are disclosed. Such compounds of the general formula (I) or ... | 06/15/2010 |
| 7259166 | Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of... | 08/21/2007 |
| 7132445 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disor... | 11/07/2006 |
| 7071342 | Synthesis of 2-hydroxy-N,N-dimethyl-3-[ [2-[1 (R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide Disclosed is a process for making the compound of formula I: using the compounds of formulas II, Q, and XI or XII: wherein A is selected from the group consi... | 07/04/2006 |
| 7049308 | C-nitroso compounds and use thereof A C-nitroso compound having a molecular weight ranging from 225 to 1,000 (from 225 to 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less th... | 05/23/2006 |
| 7030239 | Compounds to treat Alzheimer's disease The present invention is directed toward substituted hydroxyethylene compounds of formula (XII) useful in treating Alzheimer's disease and other similar diseases. ... | 04/18/2006 |
| 6906092 | Method of inhibiting matrix metalloproteinases The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I More particularly, the present invention relates to a m... | 06/14/2005 |
| 6743564 | Amine compounds, resist compositions and patterning process Amine compounds having a cyano group are useful in resist compositions for preventing a resist film from thinning and also for enhancing the resolution and focus margin of resist. ... | 06/01/2004 |
| 6710190 | 3-heteroarylalkyl substituted gaba analogs The invention is a novel series of compounds which are useful in the treatment of epilepsy, faintness attacks, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders such as irritable bowel syndrome (IB... | 03/23/2004 |
| 6710071 | Difluoromethylene aromatic ethers as inhibitors of glycine transport This invention relates to a series of difluoromethylene aromatic ethers of the formula wherein ring A and X and Y are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmace... | 03/23/2004 |
| 6605608 | Amino acid derivatives and drugs containing the same as the active ingredient The present invention relates to the compounds of the formula (I) and salts thereof (all the symbols are the same meanings as described in the specification). ##STR1## The compounds of the formula (I) possess inhibitory activity of N-type calcium cha... | 08/12/2003 |
| 6593352 | Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker Substituted anthranilic acids of the formula I ##STR1## their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker.... | 07/15/2003 |
| 6579987 | Diaryl-enynes Provided, among other things, is a compound of Formula I: ##STR1## wherein: Ar1 and Ar2 are independently selected aryl groups, optionally substituted with up to five substituents independently selected from the group consisting of a... | 06/17/2003 |
| 6548538 | Propionic acid derivatives The present application relates to novel potent PPAR-alpha-activating compounds for treating, for example, coronary heart disease, and to their preparation.... | 04/15/2003 |
| 6444840 | C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists The invention provides novel prostaglandin analogs. In particular, the present invention relates to compounds having a structure according to formula (I) wherein R1, R2, R3, R4, R5, R6, W, ... | 09/03/2002 |
| 6410780 | C11 oxymyl and hydroxylamino prostaglandins useful as medicaments The invention provides novel prostaglandin analogs. In particular, the present invention relates to compounds having a structure according to formula (I) wherein R1, R2, R3, R4, R5, R6, W, ... | 06/25/2002 |
| 6391918 | N-sulphonyl and N-sulphinyl phenylglycinamide Novel -amino acid amides of formula (I) as well as possible isomers and mixtures of isomers thereof, wherein the substituents are defined as follows: n is the number zero or one; R1 is optionally substituted alkyl, alkenyl, alkynyl, cycl... | 05/21/2002 |
| 6316630 | Synthesis of epothilones, intermediates thereto and analogues thereof The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are int... | 11/13/2001 |
| 6204388 | Synthesis of epothilones, intermediates thereto and analogues thereof The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are int... | 03/20/2001 |
| 6174915 | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses The present invention is directed to compound of the formula I: ##STR1## wherein R1, R2, R3, R4, R5, X, Y, and ##STR2## are as defined herein. These compounds are useful for inhibiting the activity of a ... | 01/16/2001 |
| 6153591 | Dipeptide caspase inhibitors and the use thereof The present invention is directed to novel dipeptides represented by the general Formula I: ##STR1## where R1 -R2 and AA are defined herein. The present invention relates to the discovery that compounds having Formula I are pote... | 11/28/2000 |
| 6107512 | Process for making optically active -amino ketones and selected novel optically active -amino ketones The invention includes selected novel optically active -amino ketones which either are themselves useful or are intermediates for the preparation of known ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitor... | 08/22/2000 |
| 6037498 | Chiral syntheses This invention relates to novel compounds of general formula (I) ##STR1## wherein R1 represents an organic group, R2 represents a hydrogen atom or an organic group, and the asterisk denotes that the group R1 is predom... | 03/14/2000 |
| 6017918 | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis The present invention provides compounds having the Formula I ##STR1## The present invention also provides methods of treating atherosclerosis, coronary heart disease, and restenosis using the compounds of Formula I, and pharmaceutical compositions c... | 01/25/2000 |
| 5856323 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase 2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira... | 01/05/1999 |
| 5840961 | Asymmetric synthesis of chiral beta-amiNo acids The invention herein is directed to a process for the preparation of ethyl 3S-amino-4-pentynoate which involves treating 3-(trimethylsilyl)-2-propynal with L-phenylglycinol in toluene to produce S-3-(trimethylsilyl)-2-propynylidene amino!benzen... | 11/24/1998 |
| 5739361 | Process for the preparation of furosemide A new process for the preparation of furosemide 4-chloro-N-(2-furylmethyl)-5-sulfamoyl-anthranilic acid!comprising the photochlorination of 4-chloro-2-fluoro-toluene to give 4-chloro-2-fluoro-benzotrichloride, the aminosulfonylation of the same and ... | 04/14/1998 |
| 5604256 | Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition Compounds of formula (I): ##STR1## (in which: R is hydrogen, methyl or hydroxy; X is alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or a heterocyclic group; A is a single bond, or an alkylene, alkenylene, alkynylene or alkadienylene group; Y is hydrogen,... | 02/18/1997 |
| 5597839 | Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics Di(aromatic) compounds corresponding to the following formula: ##STR1## in which: Ar represents either ##STR2## X represents a divalent radical, Z represents O, S or a divalent radical, and R1, R2, R3, R4 a... | 01/28/1997 |
| 5532267 | Amidinonaphthyl furancarboxylate derivatives and acid addition salts therof Amidinonaphthyl furancarboxylate derivatives of the formula I ##STR1## wherein A is a single bond or A denotes (a) a phenyl group, cyclopentyl group, or cyclohexyl group, (b) an alkenylphenyl group, alkylphenyl group, phenylalkenyl group, or phenylal... | 07/02/1996 |
| 5436244 | Indane derivatives and analgesic and diuretic compositions thereof Novel indanes in all possible stereoisomer forms of the formula ##STR1## wherein the substituents are as defined in the specification and their non-toxic, pharmaceutically acceptable acid addition salts and their hydrates having central analgesic pro... | 07/25/1995 |
| 5434151 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase 2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira... | 07/18/1995 |
| 5434181 | Furanyl insecticide The present invention relates to novel (tetrahydro-3-furanyl)methylamino derivatives of the following formula (1): ##STR1## wherein the variables are defined in the specification, which are useful as insecticides.... | 07/18/1995 |
| 5399690 | Filter dyes for photographic elements Solid particle dispersions of dyes according to the formula: ##STR1## wherein D is selected from the group consisting of ##STR2## and ketomethylene nuclei are disclosed as filter dyes for photographic elements. In this formula, E1 and... | 03/21/1995 |
| 5358938 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase 2,5-Diaryl tetrahydrofurans, 2,5-diaryl terahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiphenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respirato... | 10/25/1994 |
| 5330965 | Cyclohexenone oxime ethers and their use as herbicides Cyclohexenone oxime ethers of the formula I ##STR1## (R1 =C1 -C6 -alkyl; A=substituted or unsubstituted alkylene or alkenylene; Z=a 5-membered or 6-membered heteroaromatic structure; X=substituted or unsubstituted amino, n... | 07/19/1994 |
| 5290756 | 4-trifluoromethyl-4'-nitrodiphenyl ethers Compounds of the formula: ##STR1## wherein X is hydrogen, halo, trihalomethyl, alkyl, nitroor cyano; X1 is hydrogen, halo, or trihalomethyl; R1 and R2 are hydrogen, alkyl phenyl or benzyl; n is 1 to 5, and Z is halo, ... | 03/01/1994 |
| 5254573 | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors Novel substituted heterocyclic derivatives are provided which inhibit platelet aggregation. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.... | 10/19/1993 |
| 5234946 | Substituted alkylamine derivatives The substituted alkylamine derivatives represented by formula (I) ##STR1## wherein R1 represents (a) substituted or unsubstituted C2-6 alkenyl group, (b) substituted or unsubstituted C3-6 cycloalkenyl group, (c) subst... | 08/10/1993 |
| 5214206 | Aminosulfonyl urea ACAT inhibitors The present invention provides pharmaceutically useful compounds which are aminosulfonyl urea compounds which are ACAT inhibitors rendering them useful in controlling blood cholesterol levels, pharmaceutical compositions and methods of using the ACAT inhi... | 05/25/1993 |
